Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and alendronate for diabetic osteoporosis
ChiCTR2400093485Phase 4Completed
- Sponsor
- Taizhou People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin and alendronate in osteoporosis and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Taizhou People's Hospital. Primary endpoints: Bone mineral density and Fasting blood glucose. Started Dec 2024; status: completed.
02
Drugs
metforminalendronate
03
Conditions
osteoporosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2400093485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093485.